Back to Results
First PageMeta Content
Hematology / Bivalirudin / Direct thrombin inhibitor / Pharmacometrics / Clinical trial / Anticoagulant / Thrombin time / Heparin / Thrombocytopenia / Pharmacology / Pharmaceutical sciences / Medicine


Open Document

File Size: 1,78 MB

Share Result on Facebook

Company

The Medicines Company / D. PM Team Leader Christoffer Tornoe / /

Country

United States / /

Event

FDA Phase / /

Facility

American College of Chest Physicians / /

IndustryTerm

drug product / catalytic site / yellow solution / atrial septal closure devices / physical-chemical properties / /

MedicalCondition

congenital heart disease / thrombocytopenia/heparin-induced thrombocytopenia thrombosis syndrome / unstable angina undergoing / thrombocytopenia / congenital heart disease using / unstable angina undergoing PTCA / unstable angina / thrombosis syndrome / thrombus / suspected thrombus / /

MedicalTreatment

PTCA / percutaneous transluminal coronary angioplasty / bypass / hemodialysis / embolization / /

Organization

OCPB Division / GPI administration / Food and Drug Administration / Clinical Pharmacology Reviewer Division of Clinical Pharmacology / Team Leader Pharmacometrics Division of Pharmacometrics / Team Leader DMIHP Division of Clinical Pharmacology / American College of Chest Physicians / Pharmacometrics Reviewer Division of Pharmacometrics / /

Person

Christoffer Tornoe / Young Moon Choi / Pharmacometrics Reviewer / Arzu Selen / Ann Thorac Surg / Nitin Mehrotra / Joseph A. Grillo / /

Position

Team Leader / Executive / treating physician / representative / General / /

Product

Angiomax / mannitol / Indication Anticoagulant / Sterile Water for Injection / Code Efficacy Supplement / /

Technology

pharmacodynamics / /

URL

http /

SocialTag